A grand total of 18 medical device and diagnostic companies have debuted on the public markets this year, according to Renaissance Capital, an IPO investment and research firm.
According to the company’s data, the top-performing IPO has been Nevro. The Menlo Park, California firm had a return of 90% after its initial offer price of $18 was buoyed by investors eager to support its implanted device to treat leg and back pain through spinal cord stimulation.
Hey, check out all the engineering jobs. Post your resume today!
